Galderma joins Swiss Market Index as SMI constituent

By Public Technologies
  • Galderma begins trading as a constituent of Switzerland’s Swiss Market Index, joining the country’s 20 largest, most liquid listed companies.
  • Inclusion reflects strong growth, disciplined execution, and rising relevance in Swiss and international capital markets.
  • Net sales rose to USD 5.21 billion in 2025 from USD 4.41 billion in 2024.
  • Full-year 2026 net sales growth guidance lifted to 19-21% at constant currency; Core EBITDA margin outlook kept near 26%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galderma Group AG published the original content used to generate this news brief on September 21, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk